HIV-1 Vif: counteracting innate antiretroviral defenses.
Cullen
Bryan R
BR
Howard Hughes Medical Institute and Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA. culle002@mc.duke.edu
D000071480:APOBEC-3G Deaminase; D003564:Cytidine Deaminase; D016346:Gene Products, vif / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D009700:Nucleoside Deaminases; D011506:Proteins / Q000502:physiology; D012097:Repressor Proteins; D014779:Virus Replication / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D054320:vif Gene Products, Human Immunodeficiency Virus
D016346:Gene Products, vif; D011506:Proteins; D012097:Repressor Proteins; D054320:vif Gene Products, Human Immunodeficiency Virus; D009700:Nucleoside Deaminases; D000071480:APOBEC-3G Deaminase; C464924:APOBEC3G protein, human; D003564:Cytidine Deaminase